Navigation Links
New Platform Offers Healthcare Organizations an Unprecedented Opportunity to Align Patient Support and Data Collection

STANFORD, Calif., Aug. 15, 2017 /PRNewswire/ -- After spending the past two years building a state-of-the-art technology which consolidates patient resources and support with crowdsourced data collection, GeneFo now offers this platform to healthcare stakeholders (hospitals, foundations, biopharma companies etc.) who are interested in aligning and amplifying support, adherence, and data collection vis a vis their members, under their own brand. Three recent partnerships with medical foundations mark the successful launch of this offer.


GeneFo is a revolutionary patient platform that helps patients and caregivers better manage their conditions. It innovates by providing an integrative experience that delivers all the resources that matter in one place — from social support, self-tracking, real-time comparative tools, to medical guides, expert advice/webinars, research updates and clinical trial matching.

"Patients use the platform to enter their medical data, like symptoms, markers, and treatment protocols in order to track and compare their symptoms, progress, and treatment efficacy to others like them. And when they do, they actually optimize their care," says GeneFo's CEO, Neer Ziskind. "Following overwhelmingly positive feedback from patients and healthcare stakeholders alike regarding the added value of our online platform, we decided that we would offer our technology to healthcare organizations and nonprofits who seek a more streamlined online hub to amplify patient support, compliance, and real-world data collection, under their own brand."

Sharon Thomason, director of education at Help4HD, a Huntington's disease foundation, has recently partnered with GeneFo to create a new online community for their members. The new community will provide social support, medical resources and up-to-date research information, clinical trial matching, and real-time graphs and figures that represent the crowdsourced data patients and families contribute on the platform. "Our new community, powered by GeneFo, is a place where people who are living with Huntington's and Juvenile Huntington's disease can easily share information, get questions answered, and learn about our events and resources, all in one place. It's also a place where people can track personal information about symptoms and treatments to share with their doctors, and to the benefit of disease research."

To learn more about GeneFo, please visit us at If you are a healthcare organization interested in white-labeling GeneFo's technology please reach out to

Media Contact:
Adi Bein, VP Marketing

Related Images





Related Links

View original content with multimedia:

Copyright©2017 PR Newswire.
All rights reserved

Related biology technology :

1. Newest Port Company Revolutionizing Antibody Discovery Platforms
2. Assured Enterprises Expands its Digital Security Platform, Partnering with Qafis Ltd, TeeBase UK Ltd. and C3 Security Inc.
3. Cynvenio’s LiquidBiopsy® Platform-Derived Research Data to be Presented at the 2017 ASCO Annual Meeting, June 2-June 6, 2017 in Chicago, Illinois
4. Bioclinica Introduces Pharmaceutical Industry’s First End-to-End Clinical Financial Lifecycle Platform
5. Quorum Review IRB Joins the SMART IRB Platform
6. Validating the Cockpit™ Platform
7. Research and Markets - $5.3 Billion Next Generation Sequencing Markets, 2016-2020: Focus on Systems, Consumables, Services, Competitive Analysis, Trends, Platforms
8. SCIEX Webinar to Share Study Findings Comparing Targeted and Untargeted Lipidomics Platforms
9. EIT Digital’s Next Generation IoT Platform Set to Help Farmers Weed Out Pesticides
10. TRIANNI Signs Licensing Agreement for Transgenic Mouse Platform Use with Janssen
11. ShareVault Announces Connectors to DocuSign and Popular File Sync and Share Platforms
Post Your Comments:
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 ... overexpression experiments and avoiding the use of exogenous expression plasmids. The simplicity of ... performing systematic gain-of-function studies. , This complement to loss-of-function studies, such as ...
(Date:10/11/2017)... BioMarketing, a leading provider of patient support solutions, has announced ... network, which will launch this week. The VMS CNEs will ... to enhance the patient care experience by delivering peer-to-peer education ... professionals to help women who have been diagnosed and are ... ...
(Date:10/11/2017)... ... 11, 2017 , ... Singh Biotechnology today announced that the ... its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) B VHH13 single ... the cell membrane and bind intracellular STAT3 and inhibit its function. Dysregulation of ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and CEO of ... Club. The event entitled “Stem Cells and Their Regenerative Powers,” was ... Dr. Harman, DVM, MPVM was joined by two human doctors: Peter B. Hanson, M.D., ...
Breaking Biology Technology:
(Date:4/11/2017)... Florida , April 11, 2017 ... a security technology company, announces the appointment of independent Directors ... Bendheim to its Board of Directors, furthering the company,s ... ... of NXT-ID, we look forward to their guidance and benefiting ...
(Date:4/5/2017)... KEY FINDINGS The global market ... CAGR of 25.76% during the forecast period of 2017-2025. ... for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is segmented ... The stem cell market of the product is segmented ...
(Date:3/30/2017)... March 30, 2017 The research team of ... three-dimensional (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae ... realm of speed and accuracy for use in identification, crime investigation, ... cost. ... A research ...
Breaking Biology News(10 mins):